Rockefeller Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
VPM
ACH
VCM
GKIM
DCM
Rockefeller Capital Management's TNDM Position: Q1 2026 in Review
Rockefeller Capital Management reduced its Tandem Diabetes Care (TNDM) stake by 31% in Q1 2026, selling an estimated $4.21K and leaving 433 shares worth $8.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4072.
Rockefeller Capital Management first reported a position in TNDM in Q1 2019 and has held it in 19 quarters since. The position peaked at $3.01M in Q2 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.
- Rockefeller Capital Management held 433 shares of Tandem Diabetes Care worth $8.3K as of Q1 2026.
- Rockefeller Capital Management sold 194 Tandem Diabetes Care shares in Q1 2026, an estimated $4.21K.
- Tandem Diabetes Care made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4072 holding.
- Rockefeller Capital Management first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 19 quarters since.
- Rockefeller Capital Management's Tandem Diabetes Care position peaked at $3.01M in Q2 2020.
- 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.